In the US, babies will be vaccinated against a virus that causes respiratory tract infections
[ad_1]
The US Centers for Disease Control and Prevention (CDC) has recommended a new RSV vaccine for all infants. Respiratory syncytial virus (RSV) is a virus that causes respiratory tract infections, especially dangerous for babies. All babies under the age of 8 months should get the nirsevimab shot to protect against the disease, according to CNN. The Advisory Committee on Immunization (ACIP), which advises the CDC, voted unanimously to recommend the new injection. RSV vaccination should be added to the CDC’s childhood immunization schedule. The advisory committee also recommended that infants aged 8 to 19 months receive a second dose of nirsevimab if they have health problems that increase the risk of hospitalization. Illustrative photo: IgorVetushko/Depositphotos Nirsevimab is the first drug available to protect newborns from RSV (a virus that infects the lungs and is the main cause of hospitalization in children under one year of age). The peak incidence occurs in autumn and winter. Infants are at greatest risk of infection, with American Indian and Alaska Native children at greater risk of hospitalization. Pharmaceutical companies Sanofi and AstraZeneca, which produce “nirsevimab” under the trade name Beyfortus, promise the availability of drugs for children in a few months, just before the beginning of this year’s RSV epidemic season. We will remind you that earlier we explained the symptoms and treatment of influenza A for children and adults. Read also: Children and COVID-19: how babies transmit the coronavirus, “red flags” for parents and what to do for mothers in labor
[ad_2]
Original Source Link
